Total Liabilities: The total value of all possible claims against the corporation.
Aquestive Therapeutics, Inc. (AQST) had Total Liabilities of $188.69M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$13.82M |
|
$-22.86M |
|
$4.02M |
|
$9.80M |
|
$22.04M |
|
$-8.22M |
|
$-14.64M |
|
$-22.86M |
|
$-22.86M |
|
$-22.86M |
|
$-22.86M |
|
$-22.86M |
|
$-22.86M |
|
$-8.22M |
|
$-6.32M |
|
124.99M |
|
124.99M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$118.49M |
|
$3.96M |
|
$13.61M |
|
$132.10M |
|
$16.48M |
|
$50.65M |
|
$172.21M |
|
|
Total Liabilities |
$188.69M |
$-56.59M |
|
$-56.59M |
|
$-56.59M |
|
125.51M |
|
| Cash Flow Statement Financials | |
$-24.25M |
|
$-0.26M |
|
$1.83M |
|
$121.17M |
|
$98.49M |
|
$-22.68M |
|
$5.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.19 |
|
-- |
|
-- |
|
-8.54 |
|
-0.90 |
|
70.93% |
|
-59.51% |
|
-59.51% |
|
-- |
|
-165.45% |
|
-165.45% |
|
$-24.51M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.55 |
|
1.48 |
|
60.74 |
|
40.41% |
|
40.41% |
|
-17.31% |
|
385.44% |
|
$-0.45 |
|
$-0.20 |
|
$-0.19 |
|